850081P

Monolyso Heart CA

Avanti Research^™ - A Croda Brand 850081P, powder

• Synonyme(s) : monolysocardiolipin (Heart, Bovine) (sodium salt)
• Numéro CAS: 383907-65-1
• Code UNSPSC : 12352211
• Nomenclature NACRES : NA.25

Propriétés

• Pureté: >99% (TLC)
• Forme: powder
• Conditionnement: pkg of 1 × 10 mg (850081P-10mg)
• Fabricant/nom de marque: Avanti Research^™ - A Croda Brand 850081P
• Type de lipide: phosphoglycerides
• Conditions d'expédition: dry ice
• Température de stockage: −20°C
• Chaîne SMILES: O=P([O-])(OC[C@]([H])(O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)OCC([H])(O)COP([O-])(OC[C@]([H])(OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)=O.[Na+].[Na+]

Description

Description générale

Monolysocardiolipin (MLCL) is a class of phospholipid related to cardiolipin. MLCL is a triacylated phospholipid, uncommon in bacterial or eukaryotic membranes. MLCL is prepared from cardiolipin by the hydrolysis action of phospholipase A2 (PLA2).

Application

Monolyso Heart CA is suitable for use:

• as substrate for the synthesis of cardiolipin by the enzyme acyl-CoA:lysocardiolipin acyltransferase (ACLAT1)
• as substrate for the assay of mitochondrial monolysocardiolipin acyltransferase (MLCL AT) activity
• in the preparation of affinity resin MLCL-adriamycin-agarose for the purification of MLCL AT

Actions biochimiques/physiologiques

Monolysocardiolipin (MLCL) is a substrate for the biosynthesis of cardiolipin in heart by the activity of MLCL acyltransferase. MLCL is a marker for Barth syndrome. MLCL is implicated in apoptosis.

Conditionnement

5 mL Clear Glass Sealed Ampule (850081P-10mg)

Informations légales

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3